Motus GI Holdings
General Information | |
Business: | We have developed a single-use medical device system (the “Pure-Vu system”), cleared by the United States Food and Drug Administration (the “FDA”), that is intended to connect to standard colonoscopes to help facilitate intraprocedural cleaning of a poorly prepared colon by irrigating or cleaning the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter. The Pure-Vu system has been designed to integrate with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. Our Pure-Vu system and the procedure to cleanse the colon in preparation for colonoscopy are not currently reimbursable through private or governmental third-party payors in any country, but we intend to seek reimbursement through private or governmental third-party payors in the future. |
Industry: | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Employees: | 36 |
Founded: | 2016 |
Contact Information | |
Address | Keren Hayesod 22, Tirat Carmel, Israel, 3902638 |
Phone Number | 786 459 1831 |
Web Address | http://www.motusgi.com |
View Prospectus: | Motus GI Holdings |
Financial Information | |
Market Cap | $77.9mil |
Revenues | $0 mil (last 12 months) |
Net Income | $-7.4 mil (last 12 months) |
IPO Profile | |
Symbol | MOTS |
Exchange | NASDAQ |
Shares (millions): | 3.5 |
Price range | $5.00 - $5.00 |
Est. $ Volume | $17.5 mil |
Manager / Joint Managers | Piper Jaffray |
CO-Managers | Oppenheimer & Co. |
Expected To Trade: | 2/14/2018 |
Status: | Priced |
Quiet Period Expiration Date: | Available only to Subscribers |
Lock-Up Period Expiration Date: | Available only to Subscribers |
SCOOP Rating | Available only to Subscribers |
Rating Change | Available only to Subscribers |